DE60222734D1 - Mikropartikel und Verfahren zur deren Herstellung - Google Patents

Mikropartikel und Verfahren zur deren Herstellung

Info

Publication number
DE60222734D1
DE60222734D1 DE60222734T DE60222734T DE60222734D1 DE 60222734 D1 DE60222734 D1 DE 60222734D1 DE 60222734 T DE60222734 T DE 60222734T DE 60222734 T DE60222734 T DE 60222734T DE 60222734 D1 DE60222734 D1 DE 60222734D1
Authority
DE
Germany
Prior art keywords
active substance
microparticles
suspension
polymer
nano
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60222734T
Other languages
English (en)
Other versions
DE60222734T2 (de
Inventor
Celal Dr Albayrak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alrise Biosystems GmbH
Original Assignee
Alrise Biosystems GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alrise Biosystems GmbH filed Critical Alrise Biosystems GmbH
Publication of DE60222734D1 publication Critical patent/DE60222734D1/de
Application granted granted Critical
Publication of DE60222734T2 publication Critical patent/DE60222734T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
DE60222734T 2002-03-15 2002-03-15 Mikropartikel und Verfahren zur deren Herstellung Expired - Lifetime DE60222734T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02005393A EP1344520B1 (de) 2002-03-15 2002-03-15 Mikropartikel und Verfahren zur deren Herstellung

Publications (2)

Publication Number Publication Date
DE60222734D1 true DE60222734D1 (de) 2007-11-15
DE60222734T2 DE60222734T2 (de) 2008-07-17

Family

ID=27763347

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60222734T Expired - Lifetime DE60222734T2 (de) 2002-03-15 2002-03-15 Mikropartikel und Verfahren zur deren Herstellung

Country Status (7)

Country Link
US (1) US8802148B2 (de)
EP (1) EP1344520B1 (de)
AT (1) ATE374598T1 (de)
AU (1) AU2003230658A1 (de)
DE (1) DE60222734T2 (de)
ES (1) ES2292655T3 (de)
WO (1) WO2003077887A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE374598T1 (de) * 2002-03-15 2007-10-15 Alrise Biosystems Gmbh Mikropartikel und verfahren zur deren herstellung
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
DE10351087A1 (de) * 2003-10-31 2005-05-25 Bayer Technology Services Gmbh Feste Wirkstoff-Formulierung
FR2869801B1 (fr) * 2004-05-05 2008-09-12 Ethypharm Sa Procede de preparation de compositions a liberation prolongee et utilisation de ces compositions pour le traitement des affections chroniques du systeme nerveux central (snc)
ES2492641T3 (es) * 2005-12-22 2014-09-10 Novartis Ag Formulación de liberación sostenida que comprende octreótida y dos o más polímeros de poliláctida-co-glicólido
JP5419699B2 (ja) * 2006-10-31 2014-02-19 エボニック コーポレイション 球状化されたポリマー粒子
US8946200B2 (en) * 2006-11-02 2015-02-03 Southwest Research Institute Pharmaceutically active nanosuspensions
CA2580589C (en) * 2006-12-19 2016-08-09 Fio Corporation Microfluidic detection system
US8360321B2 (en) 2007-04-02 2013-01-29 Fio Corporation System and method of deconvolving multiplexed fluorescence spectral signals generated by quantum dot optical coding technology
JP2010530912A (ja) 2007-06-22 2010-09-16 フィオ コーポレイション 量子ドットをドープしたポリマーマイクロビーズの製造システム及び方法
CN101809433A (zh) * 2007-07-09 2010-08-18 Fio公司 用于增强试样中靶分子荧光检测的***和方法
CA2689705C (en) * 2007-07-23 2012-03-13 Fio Corporation A method and system for collating, storing, analyzing and enabling access to collected and analyzed data associated with biological and environmental test subjects
CA2702367C (en) 2007-10-12 2012-08-21 Fio Corporation Flow focusing method and system for forming concentrated volumes of microbeads, and microbeads formed further thereto
US8404850B2 (en) * 2008-03-13 2013-03-26 Southwest Research Institute Bis-quaternary pyridinium-aldoxime salts and treatment of exposure to cholinesterase inhibitors
US8652506B2 (en) * 2008-06-05 2014-02-18 Boston Scientific Scimed, Inc. Bio-degradable block co-polymers for controlled release
EP2321810A4 (de) 2008-06-25 2014-09-17 Fio Corp Biogefahr-alarmsystem
US8722706B2 (en) * 2008-08-15 2014-05-13 Southwest Research Institute Two phase bioactive formulations of bis-quaternary pyridinium oxime sulfonate salts
WO2010022519A1 (en) 2008-08-29 2010-03-04 Fio Corporation A single-use handheld diagnostic test device, and an associated system and method for testing biological and environmental test samples
US8309134B2 (en) * 2008-10-03 2012-11-13 Southwest Research Institute Modified calcium phosphate nanoparticle formation
CA2749660C (en) 2009-01-13 2017-10-31 Fio Corporation A handheld diagnostic test device and method for use with an electronic device and a test cartridge in a rapid diagnostic test
US8410455B2 (en) * 2009-04-17 2013-04-02 University Of Florida Research Foundation, Inc. Excitation-intensity-dependent, color-tunable, dual emitting nanocrystals
US9028873B2 (en) * 2010-02-08 2015-05-12 Southwest Research Institute Nanoparticles for drug delivery to the central nervous system
WO2011163469A1 (en) 2010-06-23 2011-12-29 Teva Pharmaceutical Industries Ltd. Hydrated form of anti-inflammatory roflumilast-n-oxide
GB201016436D0 (en) 2010-09-30 2010-11-17 Q Chip Ltd Method of making solid beads
GB201016433D0 (en) 2010-09-30 2010-11-17 Q Chip Ltd Apparatus and method for making solid beads
US8652366B2 (en) * 2010-11-01 2014-02-18 Board Of Regents, The University Of Texas System Aerosol-mediated particle synthesis
JP6505705B2 (ja) * 2013-12-05 2019-04-24 アルライズ バイオシステムズ ゲゼルシャフト ミット ベシュレンクテル ハフツング 経口投与用製剤の製造方法
US11154510B2 (en) 2015-06-11 2021-10-26 Alrise Biosystems Gmbh Process for the preparation of drug loaded microparticles

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2653255B2 (ja) * 1990-02-13 1997-09-17 武田薬品工業株式会社 長期徐放型マイクロカプセル
GB9211268D0 (en) * 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
JP3277342B2 (ja) * 1992-09-02 2002-04-22 武田薬品工業株式会社 徐放性マイクロカプセルの製造法
GB9412273D0 (en) * 1994-06-18 1994-08-10 Univ Nottingham Administration means
DE19508049C2 (de) * 1995-02-23 1997-02-06 Schering Ag Verwendung von Methylenmalondiesterderivaten zur Herstellung von gasenthaltenden Mikropartikeln
DE19510690A1 (de) * 1995-03-14 1996-09-19 Schering Ag Polymere Nano- und/oder Mikropartikel, Verfahren zu deren Herstellung, sowie Verwendung in medizinischen Diagnostik und Therapie
DE19545257A1 (de) * 1995-11-24 1997-06-19 Schering Ag Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
DE19611769A1 (de) * 1996-03-14 1997-09-18 Schering Ag Mikropartikel, Verfahren zu deren Herstellung, sowie deren Verwendung in der Ultraschall Diagnostik
US5858531A (en) * 1996-10-24 1999-01-12 Bio Syntech Method for preparation of polymer microparticles free of organic solvent traces
US20030049320A1 (en) * 2000-12-18 2003-03-13 Wockhardt Limited Novel in-situ forming controlled release microcarrier delivery system
CA2432900C (en) * 2000-12-21 2007-09-11 Nektar Therapeutics Induced phase transition method for the production of microparticles containing hydrophilic active agents
US20040126900A1 (en) * 2001-04-13 2004-07-01 Barry Stephen E High affinity peptide- containing nanoparticles
US7081489B2 (en) * 2001-08-09 2006-07-25 Florida State University Research Foundation Polymeric encapsulation of nanoparticles
ATE374598T1 (de) * 2002-03-15 2007-10-15 Alrise Biosystems Gmbh Mikropartikel und verfahren zur deren herstellung

Also Published As

Publication number Publication date
ATE374598T1 (de) 2007-10-15
WO2003077887A1 (en) 2003-09-25
ES2292655T3 (es) 2008-03-16
US20050106257A1 (en) 2005-05-19
US8802148B2 (en) 2014-08-12
AU2003230658A1 (en) 2003-09-29
DE60222734T2 (de) 2008-07-17
EP1344520A1 (de) 2003-09-17
EP1344520B1 (de) 2007-10-03

Similar Documents

Publication Publication Date Title
DE60222734D1 (de) Mikropartikel und Verfahren zur deren Herstellung
ATE319432T1 (de) Verfahren zur herstellung von submikropartikel- suspensionen pharmazeutischer substanzen
ATE256458T1 (de) Verfahren zur mikroverkapselung von wasserlöslichen substanzen
DK1765294T3 (da) Nukleinsyremikrokugler samt deres fremstilling og afgivelse
DE60328421D1 (de) Verfahren zur herstellung von super-hydrophoben oberflächen, daraus hergestellte oberflächen und deren verwendung
DE50104019D1 (de) Verfahren zur agglomeration dispergierter kautschuke
ATE342316T1 (de) Verfahren zur herstellung von mikroperlen die fettlösliche substanzen enthalten
DE602005025177D1 (de) Verfahren zur Herstellung einer wässrigen Dispersion enthaltend einen Komplex von Poly(3,4-dialkoxythiophen) und einem Polyanion
DE602004020179D1 (de) Peptidenanostrukturen die fremdmaterial enthalten, und verfahren zur herstellung derselben
ATE405606T1 (de) Poröse polymerische vesikel sowie verfahren zu deren herstellung
ATE147976T1 (de) Protein nanomatrizen und verfahren zur herstellung
ATE426586T1 (de) Verfahren zur herstellung von cyclohexanon und cyclohexanol
DE502005001316D1 (de) Verfahren zur herstellung von gut in wasser redispergierbaren polymerisatpulvern
ATE404588T1 (de) Verfahren zur herstellung von chondroitinsulfaten aus k4-polysaccharid und so hergestellte produkte
DE60143261D1 (de) Hämatologie-blutkontrolle und verfahren zu ihrer herstellung
TW200722461A (en) Method of producing cyclic polyolefin film, cyclic polyolefin film produced by the production method, method of preparing liquid dispersion of fine particles, liquid dispersion of fine particles and method of preparing dope
DE602004026096D1 (de) Verfahren zur herstellung von polyacrolein
DE602005026314D1 (de) Verfahren und vorrichtung zur herstellung von polymerschaumkügelchen oder -ballons
ATE514746T1 (de) Kohlenstoffnanoröhrchen verstärkte polymerzusammensetzung und verfahren zu deren herstellung
EP2324864A4 (de) Verbundmaterial mit einer matrix von hohem molekulargewicht und einem verbundstoff von niedrigem molekulargewicht sowie verfahren zu seiner herstellung
DE60034765D1 (de) Verfahren zur herstellung von poly(p-dioxanon), und poly(p-dioxanon)-monofilament und verfahren zur herstellung desselben
ATE420168T1 (de) Verfahren zur herstellung von extrachromosomalen nukleinsäuremolekülen
ATE324617T1 (de) Verfahren und vorrichtung zur herstellung von körnern eines silbersalzes einer organischen säure und verfahren zur herstellung wärmeentwickelter bildaufzeichnungsmaterialien
DE60107189D1 (de) Verfahren zur Herstellung von wasserfreien Mirtazapin-Kristallen.
DE60125226D1 (de) Verfahren zur herstellung von partikelförmigen polymerisaten

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: ALBAYRAK, CELAL DR., 82152 PLANEGG, DE

8364 No opposition during term of opposition